Absorica (Ranbaxy Laboratories Inc.)
Welcome to the PulseAid listing for the Absorica drug offered from Ranbaxy Laboratories Inc.. This Retinoid [EPC],Retinoids [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Ranbaxy Laboratories Inc. |
NON-PROPRIETARY NAME: | isotretinoin |
SUBSTANCE NAME: | ISOTRETINOIN |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Retinoid [EPC],Retinoids [Chemical/Ingredient] |
ROUTE: | ORAL |
DOSAGE FORM: | CAPSULE |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-06-08 |
END MARKETING DATE: | 0000-00-00 |
Absorica HUMAN PRESCRIPTION DRUG Details:
Item Description | Absorica from Ranbaxy Laboratories Inc. |
LABELER NAME: | Ranbaxy Laboratories Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 10(mg/1) |
START MARKETING DATE: | 2012-06-08 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 10631-115_83c5bc5c-9073-4903-9bda-a3452e6ddac6 |
PRODUCT NDC: | 10631-115 |
APPLICATION NUMBER: | NDA021951 |
Other ISOTRETINOIN Pharmaceutical Manufacturers / Labelers: